Copyright 2009 Medical News Today Latest Menopause News From Medical News Today. http://www.medicalnewstoday.com/sections/menopause/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Mon, 09 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170262.php http://www.medicalnewstoday.com/articles/170262.php Researchers in the US found that the decline in use of postmenopausal hormone therapy may partly explain the fall in incidence of a known risk factor for breast cancer, atypical ductal hyperplasia. They also said their findings support the idea that low and high grade breast cancers develop via different pathways and thereby clarify the role that hormone therapy may play in increasing the rates of breast cancer. Breast Cancer Mon, 09 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170265.php http://www.medicalnewstoday.com/articles/170265.php The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. "Postmenopausal hormone treatment is associated with increased rates of benign breast biopsies, and early and late stages of cancer. Breast Cancer Thu, 05 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/169964.php http://www.medicalnewstoday.com/articles/169964.php For estrogen replacement to provide stroke protection, it likely must be given soon after levels drop because of menopause or surgical removal of the ovaries, scientists report in the Journal of Neuroscience. Stroke Thu, 29 Oct 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/169161.php http://www.medicalnewstoday.com/articles/169161.php Hormone replacement therapy (HRT) to treat menopausal estrogen deficiency has been in widespread use for over 60 years. Several observational studies over the years showed that HRT use by younger postmenopausal women was associated with a significant reduction in total mortality; available evidence supported the routine use of HRT to increase longevity in postmenopausal women. Menopause Fri, 23 Oct 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/168413.php http://www.medicalnewstoday.com/articles/168413.php Earlier this year, the BBC reported that "HRT - Hormone Replacement Therapy - can shrink women's brains"1, after a study was published which showed that brain volume in women taking HRT was smaller in two key areas involved in thinking and memory. Menopause Tue, 20 Oct 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/168017.php http://www.medicalnewstoday.com/articles/168017.php The right combination of estrogen and a selective estrogen receptor modulator (SERM), which blocks the effects of estrogen in breast tissue, could relieve menopause symptoms and cut breast cancer risk, Yale researchers report in an abstract presented at the American Society for Reproductive Medicine (ASRM) scientific meeting in Atlanta, Georgia, October 17-21. Breast Cancer Wed, 14 Oct 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/167205.php http://www.medicalnewstoday.com/articles/167205.php Depomed, Inc. (NASDAQ:DEPO) announced top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes. In the higher dose treatment arm of the two doses evaluated, the 1800mg dose achieved positive results at 4 weeks. Menopause Tue, 13 Oct 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/167181.php http://www.medicalnewstoday.com/articles/167181.php Women who developed new-onset breast tenderness after starting estrogen plus progestin hormone replacement therapy were at significantly higher risk for developing breast cancer than women on the combination therapy who didn't experience such tenderness, according to a new UCLA study. The research, published in the Oct. Menopause Sat, 10 Oct 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/166923.php http://www.medicalnewstoday.com/articles/166923.php SE5-OH containing Natural S-equol, a novel soy germ-based ingredient in a supplement, improved menopausal symptoms, including significantly reducing hot flash frequency by nearly 59 percent, according to a peer-reviewed study in Japanese women. This key study was presented in an oral presentation at the North American Menopause Society (NAMS) 20th annual meeting. Menopause Tue, 06 Oct 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/166448.php http://www.medicalnewstoday.com/articles/166448.php Michael Holick, PhD, MD, director of the Bone Healthcare Clinic and the Vitamin D, Skin and Bone Research Laboratory at Boston University School of Medicine BUSM recently received the 2009 NAMS/Upsher-Smith Laboratories, Inc.Vitamin D Research Award from the North American Menopause Society (NAMS). Holick was presented with the award during NAMS' 20th annual meeting in San Diego, California on September 30 - October 3, 2009. NAMS/Upsher-Smith Laboratories, Inc. Menopause Thu, 01 Oct 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/165871.php http://www.medicalnewstoday.com/articles/165871.php Post-menopausal women who engage in moderate to vigorous exercise have a reduced risk of breast cancer. This comes from researchers writing the open access journal BMC Cancer who investigated the link between breast cancer and exercise. "With an estimated 182,460 new cases diagnosed in the United States in 2008, breast cancer is recognized as the most common cancer affecting U.S. women" says Dr. Tricia M Peters from the U.S. Breast Cancer Wed, 30 Sep 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/165705.php http://www.medicalnewstoday.com/articles/165705.php Pre- and post-menopausal women who self-rated themselves as being sexually satisfied had a higher overall psychological well-being score and scores for "positive well-being" and "vitality," compared with sexually dissatisfied women in a study of 295 women sexually active more than twice a month. The study, published in The Journal of Sexual Medicine, also uncovered a positive association between age and well-being, but a negative association for general health. Women's Health / Gynecology Tue, 29 Sep 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/165570.php http://www.medicalnewstoday.com/articles/165570.php Researchers from Boston University School of Medicine (BUSM) are recommending that menopausal women on hormone therapy (HT) continue their treatment prior to having their annual mammogram screenings. These recommendations appear as an editorial in the current on-line issue of Journal of the North American Menopause Society. Menopause Wed, 23 Sep 2009 06:00:00 PST http://www.medicalnewstoday.com/articles/164931.php http://www.medicalnewstoday.com/articles/164931.php Researchers have identified a mechanism that may keep a well known signaling molecule from eroding bone and inflaming joints, according to an early study published online in the Journal of Clinical Investigation. Bone is continually recycled to maintain its strength through the competing action of osteoclasts, cells that break down aging bone, and osteoblasts, which build new bone. Arthritis / Rheumatology Wed, 23 Sep 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/164908.php http://www.medicalnewstoday.com/articles/164908.php New research has found that switching post-menopausal women with early breast cancer to the drug exemestane (Aromasin) after two or three years of tamoxifen rather than keeping them on tamoxifen for five years improves the chance of remaining cancer free and reduces the risk of death for at least the next six years. Breast Cancer Wed, 23 Sep 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/164910.php http://www.medicalnewstoday.com/articles/164910.php The largest study in the world of treatments for post menopausal, hormone positive breast cancer has shown that patients who continue to take exemestane or tamoxifen do significantly better than patients who start to take one or other drug (or tamoxifen followed exemestane) but then stop. Breast Cancer Wed, 23 Sep 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/164872.php http://www.medicalnewstoday.com/articles/164872.php Women who take hormone replacement therapy are nearly twice as likely to die from lung cancer, according to a study published in the journal Lancet, the Los Angeles Times reports. Menopause Mon, 21 Sep 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/164580.php http://www.medicalnewstoday.com/articles/164580.php Marilyn Graham was 56 when she signed up for a grueling hour of cycling each morning for 12 weeks, occasionally decked out in a mask, a heart monitor and a bag of intravenous fluid and subjected to needle pricks to obtain blood samples. "I was probably the biggest whiner of the group, complaining loudly about the seats and how my butt hurt," said Graham, who writes software for business units on the University of California, Berkeley campus. Cardiovascular / Cardiology Wed, 09 Sep 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/163260.php http://www.medicalnewstoday.com/articles/163260.php Gabapentin, a drug initially used to treat seizures, improves sleep quality in menopausal women with hot flashes, University of Rochester Medical Center researchers report online and in the September issue of the Journal of Women's Health. Approximately 40 percent of menopausal women experience sleep disruption, often in the form of difficulty with sleep initiation and frequent nighttime awakenings. Menopause Fri, 04 Sep 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/162882.php http://www.medicalnewstoday.com/articles/162882.php Dietary supplements claiming to help postmenopausal women with bone health may not be doing what they say, according to new research from Purdue University. "We found that some plant-derived isoflavones have a modest effect on suppressing bone loss during post-menopause, but more concerning is many dietary supplements that claim to have the power of estrogen do not," said Connie Weaver, distinguished professor of foods and nutrition. "It's buyer beware. Menopause Mon, 24 Aug 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/161563.php http://www.medicalnewstoday.com/articles/161563.php Postmenopausal women with breast cancer who are treated with the drug letrozole show increased survival rates after surgery compared with those treated with the drug tamoxifen, which is more widely used, according to a study published Thursday in the New England Journal of Medicine, Breast Cancer Fri, 21 Aug 2009 16:00:00 PST http://www.medicalnewstoday.com/articles/161483.php http://www.medicalnewstoday.com/articles/161483.php In middle-aged women, visceral fat, more commonly called belly fat, is known to be a significant risk factor for cardiovascular disease, but what causes visceral fat to accumulate? The culprit is likely not age, as is commonly believed, but the change in hormone balance that occurs during the menopause transition, according to researchers at Rush University Medical Center. Menopause Tue, 18 Aug 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/161035.php http://www.medicalnewstoday.com/articles/161035.php For many women, the word "menopause" means living with innumerable symptoms which can alter the course of their lives. Menopause affects nearly 40 million women in the United States and while it is a natural time of physical and emotional change, it can also be a time of confusion and worry. Common symptoms include hot flashes, night sweats, insomnia, irritability, low libido, and depression. Hot Flashes are the most common symptom experienced by menopausal women. Menopause Thu, 23 Jul 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/158445.php http://www.medicalnewstoday.com/articles/158445.php Women who have premature menopause because of medical interventions are at an increased risk of developing lung cancer, according to a new study published in the International Journal of Cancer. The startling link was made by epidemiologists from the Université de Montréal, the Research Centre of the Centre Hospitalier de l'Université de Montréal and the INRS - Institut Armand-Frappier. Women's Health / Gynecology Wed, 15 Jul 2009 11:00:00 PST http://www.medicalnewstoday.com/articles/157658.php http://www.medicalnewstoday.com/articles/157658.php New results show that postmenopausal women with breast cancer receiving adjuvant letrozole have better cognitive function than women being treated with tamoxifen. The data, from a recent meeting of the American Society of Clinical Oncology (ASCO), are drawn from a sub-study of the Breast International Group (BIG) 1-98 trial. Breast Cancer